Therefore, the loss of PPARγ in Treg impairs their ability to control effector CD4+ T-cell responses preventing protection against colitis in a mouse model of intestinal inflammation suggesting that expression of PPARγ by Treg is required for optimal anti-inflammatory efficacy [31]. The gene discussed is PPARG; the disease is colitis.